{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:27:24Z","timestamp":1780957644204,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.vaccine.2010.04.005","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T08:49:08Z","timestamp":1271666948000},"page":"4052-4058","source":"Crossref","is-referenced-by-count":12,"title":["Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism"],"prefix":"10.1016","volume":"28","author":[{"given":"Zhaohui","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.04.005_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/smim.2001.0310","article-title":"Oral tolerance","volume":"13","author":"Garside","year":"2001","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jaut.1997.0148","article-title":"Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines","volume":"10","author":"Polanski","year":"1997","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2010.04.005_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-8227(99)00080-7","article-title":"Human insulin B chain but not A chain decreases the rate of diabetes in BB rats","volume":"46","author":"Song","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.vaccine.2010.04.005_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/jaut.1996.0047","article-title":"Antigen based therapies to prevent diabetes in NOD mice","volume":"9","author":"Ramiya","year":"1996","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2010.04.005_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000191318","article-title":"Insulin in diabetes prevention","volume":"48S","author":"Ramiya","year":"1997","journal-title":"Horm Res"},{"key":"10.1016\/j.vaccine.2010.04.005_bib6","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1073\/pnas.94.9.4610","article-title":"A cholera toxoid\u2013insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes","volume":"94","author":"Bergerot","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.04.005_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1018487401810","article-title":"Expression of cholera toxin B subunit oligomers in transgenic potato plants","volume":"6","author":"Arakawa","year":"1997","journal-title":"Transgenic Res"},{"key":"10.1016\/j.vaccine.2010.04.005_bib8","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2337\/diabetes.48.11.2150","article-title":"Oral administration of cholera toxin B\u2013insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells","volume":"48","author":"Ploix","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.vaccine.2010.04.005_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt1098-934","article-title":"A plant-based cholera toxin B subunit\u2013insulin fusion protein protects against the development of autoimmune diabetes","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jbiotec.2005.05.027","article-title":"Oral administration of a cholera toxin B subunit\u2013insulin fusion protein produced in silkworm protects against autoimmune diabetes","volume":"119","author":"Gong","year":"2005","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib11","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJM199411243312107","article-title":"The pathogenesis of insulin-dependent diabetes mellitus","volume":"331","author":"Atkinson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.04.005_bib12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1084\/jem.183.4.1561","article-title":"Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes","volume":"183","author":"Tian","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.04.005_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s002510000173","article-title":"Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice","volume":"51","author":"Ogino","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2010.04.005_bib14","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.4049\/jimmunol.166.5.2982","article-title":"Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes","volume":"166","author":"Quinn","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/366069a0","article-title":"Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes","volume":"366","author":"Kaufman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.04.005_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/366072a0","article-title":"Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice","volume":"366","author":"Tisch","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.04.005_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pep.2009.04.002","article-title":"Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli","volume":"66","author":"Gong","year":"2009","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2010.04.005_bib18","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","article-title":"Cholera toxin B subunit: an efficient transmucosal carrier\u2013delivery system for induction of peripheral immunological tolerance","volume":"91","author":"Sun","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.04.005_bib19","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2006.10.039","article-title":"Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine expressed in silkworm","volume":"25","author":"Gong","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.04.005_bib20","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1073\/pnas.88.22.10252","article-title":"Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin","volume":"88","author":"Zhang","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.04.005_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0797-793","article-title":"Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance","volume":"3","author":"Ma","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.04.005_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/17402520600876804","article-title":"Oral tolerance: therapeutic implications for autoimmune diseases","volume":"13","author":"Faria","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.163.3.1178","article-title":"Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent","volume":"163","author":"Tisch","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/intimm\/13.6.835","article-title":"Induction of a type 1 regulatory CD4 T cell response following V beta 8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis","volume":"13","author":"Kumar","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.180.1.58","article-title":"A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice","volume":"180","author":"Jin","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1006\/jaut.1994.1048","article-title":"Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide","volume":"7","author":"Chen","year":"1994","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2010.04.005_bib27","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/nm1296-1348","article-title":"Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice","volume":"2","author":"Tian","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.04.005_bib28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00125-002-0806-9","article-title":"Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase","volume":"45","author":"Jun","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.vaccine.2010.04.005_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.molimm.2003.09.007","article-title":"Molecular profile of the T cell receptors of regulatory and effector CD4+ T cells recognizing overlapping determinants on glutamic acid decarboxylase (524\u2013543)","volume":"40","author":"Im","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib30","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.4049\/jimmunol.174.8.4516","article-title":"Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD (500\u2013585)","volume":"174","author":"Han","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1196\/annals.1394.001","article-title":"Autoreactive T cells in a partially humanized murine model of T1D","volume":"1103","author":"Gebe","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2010.04.005_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2007.08.001","article-title":"Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice","volume":"30","author":"Gebe","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2010.04.005_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12026-008-8090-5","article-title":"Parameters influencing antigen-specific immunotherapy for Type 1 diabetes","volume":"42","author":"Wang","year":"2008","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2010.04.005_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2009.02.004","article-title":"Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice","volume":"33","author":"Elagin","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2010.04.005_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.2002.01988.x","article-title":"Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice","volume":"130","author":"Aspord","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2010.04.005_bib36","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1084\/jem.184.6.2167","article-title":"Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes","volume":"184","author":"Harrison","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.04.005_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-065X.2000.917303.x","article-title":"Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model","volume":"173","author":"H\u00e4nninen","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2010.04.005_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jdiacomp.2004.12.003","article-title":"Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes","volume":"19","author":"Agardh","year":"2005","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.vaccine.2010.04.005_bib39","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(01)06801-5","article-title":"Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial","volume":"358","author":"Raz","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.04.005_bib40","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/diabetes.54.6.1763","article-title":"A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala\u2013Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes","volume":"54","author":"Herold","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.vaccine.2010.04.005_bib41","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.04.005_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1515\/JPEM.2001.14.S1.619","article-title":"Update on major trials for the prevention of type 1 diabetes mellitus: the American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)","volume":"14","author":"Schatz","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.vaccine.2010.04.005_bib43","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial\u2014Type 1","volume":"28","author":"Skyler","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vaccine.2010.04.005_bib44","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s001250051482","article-title":"No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group","volume":"43","author":"Pozzilli","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.vaccine.2010.04.005_bib45","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00125-007-0694-0","article-title":"Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study","volume":"50","author":"Barker","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.vaccine.2010.04.005_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1196\/annals.1309.057","article-title":"Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes","volume":"1029","author":"Ergun-Longmire","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2010.04.005_bib47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1552-6356.2003.tb00112.x","article-title":"Oral insulin doesn\u2019t prevent type 1 diabetes","volume":"7","author":"Cockey","year":"2003","journal-title":"AWHONN Lifelines"},{"key":"10.1016\/j.vaccine.2010.04.005_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1900\/RDS.2004.1.113","article-title":"Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?","volume":"1","author":"Hanninen","year":"2004","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.vaccine.2010.04.005_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2006.09.013","article-title":"Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?","volume":"6","author":"Bresson","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2010.04.005_bib50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.humimm.2009.06.018","article-title":"Oral tolerance: can we make it work?","volume":"70","author":"Ilan","year":"2009","journal-title":"Hum Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T21:00:27Z","timestamp":1685566827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10004986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":50,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0264410X10004986"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}